0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Cell and Gene Therapy Manufacturing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-34P13437
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cell and Gene Therapy Manufacturing Services Market Research Report 2023
BUY CHAPTERS

Cell and Gene Therapy Manufacturing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-34P13437
Report
December 2024
Pages:141
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cell and Gene Therapy Manufacturing Services - Market Size

The global market for Cell and Gene Therapy Manufacturing Services was estimated to be worth US$ 4729.8 million in 2023 and is forecast to a readjusted size of US$ 8643.5 million by 2030 with a CAGR of 8.9% during the forecast period 2024-2030

Cell and Gene Therapy Manufacturing Services - Market

Cell and Gene Therapy Manufacturing Services - Market

Gene therapy aims to treat disorders by replacing or introducing genes into cells— either inside the body (in vivo) or outside of the body (ex vivo).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Manufacturing Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cell and Gene Therapy Manufacturing Services by region & country, by Type, and by Application.
The Cell and Gene Therapy Manufacturing Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Manufacturing Services.
Market Segmentation

Scope of Cell and Gene Therapy Manufacturing Services - Market Report

Report Metric Details
Report Name Cell and Gene Therapy Manufacturing Services - Market
Forecasted market size in 2030 US$ 8643.5 million
CAGR 8.9%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Oncology Diseases
  • Cardiovascular Diseases
  • Orthopedic Diseases
  • Ophthalmology Diseases
  • Infectious Diseases
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, Lonza, Catalent, WuXi AppTec, Takara Bio Inc, Nikon Corporation, FUJIFILM Holdings Corporation, F. Hoffmann-La Roche, Oxford Biomedica Plc, Cell and Gene Therapy Catapult, The Discovery Labs LLC, RoslinCT, JRS PHARMA, FinVector, ABL, Resilience, BioCentriq, Porton Biopharma Limited, Andelyn Biosciences, Commercializing Living Therapies, Vibalogics, Anemocyte Srl, ElevateBio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Cell and Gene Therapy Manufacturing Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Cell and Gene Therapy Manufacturing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Cell and Gene Therapy Manufacturing Services in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Cell and Gene Therapy Manufacturing Services - Market size in 2030?

Ans: The Cell and Gene Therapy Manufacturing Services - Market size in 2030 will be US$ 8643.5 million.

Who are the main players in the Cell and Gene Therapy Manufacturing Services - Market report?

Ans: The main players in the Cell and Gene Therapy Manufacturing Services - Market are Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, Lonza, Catalent, WuXi AppTec, Takara Bio Inc, Nikon Corporation, FUJIFILM Holdings Corporation, F. Hoffmann-La Roche, Oxford Biomedica Plc, Cell and Gene Therapy Catapult, The Discovery Labs LLC, RoslinCT, JRS PHARMA, FinVector, ABL, Resilience, BioCentriq, Porton Biopharma Limited, Andelyn Biosciences, Commercializing Living Therapies, Vibalogics, Anemocyte Srl, ElevateBio

What are the Application segmentation covered in the Cell and Gene Therapy Manufacturing Services - Market report?

Ans: The Applications covered in the Cell and Gene Therapy Manufacturing Services - Market report are Oncology Diseases, Cardiovascular Diseases, Orthopedic Diseases, Ophthalmology Diseases, Infectious Diseases, Others

What are the Type segmentation covered in the Cell and Gene Therapy Manufacturing Services - Market report?

Ans: The Types covered in the Cell and Gene Therapy Manufacturing Services - Market report are By Cell Therapy, Allogeneic, Autologous, Viral Vector, By Gene Therapy, Non-viral Vector, Oligonucleotides, Virus Vector

Recommended Reports

Cell Therapy Services

Gene & RNA Therapy

Biopharma Manufacturing

1 Market Overview
1.1 Cell and Gene Therapy Manufacturing Services Product Introduction
1.2 Global Cell and Gene Therapy Manufacturing Services Market Size Forecast
1.3 Cell and Gene Therapy Manufacturing Services Market Trends & Drivers
1.3.1 Cell and Gene Therapy Manufacturing Services Industry Trends
1.3.2 Cell and Gene Therapy Manufacturing Services Market Drivers & Opportunity
1.3.3 Cell and Gene Therapy Manufacturing Services Market Challenges
1.3.4 Cell and Gene Therapy Manufacturing Services Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cell and Gene Therapy Manufacturing Services Players Revenue Ranking (2023)
2.2 Global Cell and Gene Therapy Manufacturing Services Revenue by Company (2019-2024)
2.3 Key Companies Cell and Gene Therapy Manufacturing Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cell and Gene Therapy Manufacturing Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Cell and Gene Therapy Manufacturing Services
2.6 Cell and Gene Therapy Manufacturing Services Market Competitive Analysis
2.6.1 Cell and Gene Therapy Manufacturing Services Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cell and Gene Therapy Manufacturing Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Allogeneic
3.1.2 Autologous
3.1.3 Viral Vector
3.2 Global Cell and Gene Therapy Manufacturing Services Sales Value by Type
3.2.1 Global Cell and Gene Therapy Manufacturing Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cell and Gene Therapy Manufacturing Services Sales Value, by Type (2019-2030)
3.2.3 Global Cell and Gene Therapy Manufacturing Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oncology Diseases
4.1.2 Cardiovascular Diseases
4.1.3 Orthopedic Diseases
4.1.4 Ophthalmology Diseases
4.1.5 Infectious Diseases
4.1.6 Others
4.2 Global Cell and Gene Therapy Manufacturing Services Sales Value by Application
4.2.1 Global Cell and Gene Therapy Manufacturing Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cell and Gene Therapy Manufacturing Services Sales Value, by Application (2019-2030)
4.2.3 Global Cell and Gene Therapy Manufacturing Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cell and Gene Therapy Manufacturing Services Sales Value by Region
5.1.1 Global Cell and Gene Therapy Manufacturing Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cell and Gene Therapy Manufacturing Services Sales Value by Region (2019-2024)
5.1.3 Global Cell and Gene Therapy Manufacturing Services Sales Value by Region (2025-2030)
5.1.4 Global Cell and Gene Therapy Manufacturing Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cell and Gene Therapy Manufacturing Services Sales Value, 2019-2030
5.2.2 North America Cell and Gene Therapy Manufacturing Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cell and Gene Therapy Manufacturing Services Sales Value, 2019-2030
5.3.2 Europe Cell and Gene Therapy Manufacturing Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cell and Gene Therapy Manufacturing Services Sales Value, 2019-2030
5.4.2 Asia Pacific Cell and Gene Therapy Manufacturing Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cell and Gene Therapy Manufacturing Services Sales Value, 2019-2030
5.5.2 South America Cell and Gene Therapy Manufacturing Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cell and Gene Therapy Manufacturing Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cell and Gene Therapy Manufacturing Services Sales Value
6.3 United States
6.3.1 United States Cell and Gene Therapy Manufacturing Services Sales Value, 2019-2030
6.3.2 United States Cell and Gene Therapy Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cell and Gene Therapy Manufacturing Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cell and Gene Therapy Manufacturing Services Sales Value, 2019-2030
6.4.2 Europe Cell and Gene Therapy Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cell and Gene Therapy Manufacturing Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cell and Gene Therapy Manufacturing Services Sales Value, 2019-2030
6.5.2 China Cell and Gene Therapy Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cell and Gene Therapy Manufacturing Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cell and Gene Therapy Manufacturing Services Sales Value, 2019-2030
6.6.2 Japan Cell and Gene Therapy Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cell and Gene Therapy Manufacturing Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cell and Gene Therapy Manufacturing Services Sales Value, 2019-2030
6.7.2 South Korea Cell and Gene Therapy Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cell and Gene Therapy Manufacturing Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cell and Gene Therapy Manufacturing Services Sales Value, 2019-2030
6.8.2 Southeast Asia Cell and Gene Therapy Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cell and Gene Therapy Manufacturing Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cell and Gene Therapy Manufacturing Services Sales Value, 2019-2030
6.9.2 India Cell and Gene Therapy Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cell and Gene Therapy Manufacturing Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Merck KGaA
7.2.1 Merck KGaA Profile
7.2.2 Merck KGaA Main Business
7.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.2.4 Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.2.5 Merck KGaA Recent Developments
7.3 Charles River Laboratories
7.3.1 Charles River Laboratories Profile
7.3.2 Charles River Laboratories Main Business
7.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.3.4 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.3.5 Lonza Recent Developments
7.4 Lonza
7.4.1 Lonza Profile
7.4.2 Lonza Main Business
7.4.3 Lonza Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.4.4 Lonza Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.4.5 Lonza Recent Developments
7.5 Catalent
7.5.1 Catalent Profile
7.5.2 Catalent Main Business
7.5.3 Catalent Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.5.4 Catalent Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.5.5 Catalent Recent Developments
7.6 WuXi AppTec
7.6.1 WuXi AppTec Profile
7.6.2 WuXi AppTec Main Business
7.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.6.4 WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.6.5 WuXi AppTec Recent Developments
7.7 Takara Bio Inc
7.7.1 Takara Bio Inc Profile
7.7.2 Takara Bio Inc Main Business
7.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.7.4 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.7.5 Takara Bio Inc Recent Developments
7.8 Nikon Corporation
7.8.1 Nikon Corporation Profile
7.8.2 Nikon Corporation Main Business
7.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.8.4 Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.8.5 Nikon Corporation Recent Developments
7.9 FUJIFILM Holdings Corporation
7.9.1 FUJIFILM Holdings Corporation Profile
7.9.2 FUJIFILM Holdings Corporation Main Business
7.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.9.4 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.9.5 FUJIFILM Holdings Corporation Recent Developments
7.10 F. Hoffmann-La Roche
7.10.1 F. Hoffmann-La Roche Profile
7.10.2 F. Hoffmann-La Roche Main Business
7.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.10.4 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.10.5 F. Hoffmann-La Roche Recent Developments
7.11 Oxford Biomedica Plc
7.11.1 Oxford Biomedica Plc Profile
7.11.2 Oxford Biomedica Plc Main Business
7.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.11.4 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.11.5 Oxford Biomedica Plc Recent Developments
7.12 Cell and Gene Therapy Catapult
7.12.1 Cell and Gene Therapy Catapult Profile
7.12.2 Cell and Gene Therapy Catapult Main Business
7.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.12.4 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.12.5 Cell and Gene Therapy Catapult Recent Developments
7.13 The Discovery Labs LLC
7.13.1 The Discovery Labs LLC Profile
7.13.2 The Discovery Labs LLC Main Business
7.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.13.4 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.13.5 The Discovery Labs LLC Recent Developments
7.14 RoslinCT
7.14.1 RoslinCT Profile
7.14.2 RoslinCT Main Business
7.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.14.4 RoslinCT Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.14.5 RoslinCT Recent Developments
7.15 JRS PHARMA
7.15.1 JRS PHARMA Profile
7.15.2 JRS PHARMA Main Business
7.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.15.4 JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.15.5 JRS PHARMA Recent Developments
7.16 FinVector
7.16.1 FinVector Profile
7.16.2 FinVector Main Business
7.16.3 FinVector Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.16.4 FinVector Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.16.5 FinVector Recent Developments
7.17 ABL
7.17.1 ABL Profile
7.17.2 ABL Main Business
7.17.3 ABL Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.17.4 ABL Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.17.5 ABL Recent Developments
7.18 Resilience
7.18.1 Resilience Profile
7.18.2 Resilience Main Business
7.18.3 Resilience Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.18.4 Resilience Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.18.5 Resilience Recent Developments
7.19 BioCentriq
7.19.1 BioCentriq Profile
7.19.2 BioCentriq Main Business
7.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.19.4 BioCentriq Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.19.5 BioCentriq Recent Developments
7.20 Porton Biopharma Limited
7.20.1 Porton Biopharma Limited Profile
7.20.2 Porton Biopharma Limited Main Business
7.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.20.4 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.20.5 Porton Biopharma Limited Recent Developments
7.21 Andelyn Biosciences
7.21.1 Andelyn Biosciences Profile
7.21.2 Andelyn Biosciences Main Business
7.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.21.4 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.21.5 Andelyn Biosciences Recent Developments
7.22 Commercializing Living Therapies
7.22.1 Commercializing Living Therapies Profile
7.22.2 Commercializing Living Therapies Main Business
7.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.22.4 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.22.5 Commercializing Living Therapies Recent Developments
7.23 Vibalogics
7.23.1 Vibalogics Profile
7.23.2 Vibalogics Main Business
7.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.23.4 Vibalogics Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.23.5 Vibalogics Recent Developments
7.24 Anemocyte Srl
7.24.1 Anemocyte Srl Profile
7.24.2 Anemocyte Srl Main Business
7.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.24.4 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.24.5 Anemocyte Srl Recent Developments
7.25 ElevateBio
7.25.1 ElevateBio Profile
7.25.2 ElevateBio Main Business
7.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
7.25.4 ElevateBio Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.25.5 ElevateBio Recent Developments
8 Industry Chain Analysis
8.1 Cell and Gene Therapy Manufacturing Services Industrial Chain
8.2 Cell and Gene Therapy Manufacturing Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cell and Gene Therapy Manufacturing Services Sales Model
8.5.2 Sales Channel
8.5.3 Cell and Gene Therapy Manufacturing Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Cell and Gene Therapy Manufacturing Services Market Trends
    Table 2. Cell and Gene Therapy Manufacturing Services Market Drivers & Opportunity
    Table 3. Cell and Gene Therapy Manufacturing Services Market Challenges
    Table 4. Cell and Gene Therapy Manufacturing Services Market Restraints
    Table 5. Global Cell and Gene Therapy Manufacturing Services Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Cell and Gene Therapy Manufacturing Services Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Cell and Gene Therapy Manufacturing Services Product Type
    Table 9. Key Companies Time to Begin Mass Production of Cell and Gene Therapy Manufacturing Services
    Table 10. Global Cell and Gene Therapy Manufacturing Services Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing Services as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Cell and Gene Therapy Manufacturing Services Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Cell and Gene Therapy Manufacturing Services Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Cell and Gene Therapy Manufacturing Services Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Cell and Gene Therapy Manufacturing Services Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Cell and Gene Therapy Manufacturing Services Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Cell and Gene Therapy Manufacturing Services Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Cell and Gene Therapy Manufacturing Services Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Cell and Gene Therapy Manufacturing Services Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Cell and Gene Therapy Manufacturing Services Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Cell and Gene Therapy Manufacturing Services Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Cell and Gene Therapy Manufacturing Services Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Cell and Gene Therapy Manufacturing Services Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Cell and Gene Therapy Manufacturing Services Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Cell and Gene Therapy Manufacturing Services Sales Value by Region (2019-2024) & (%)
    Table 27. Global Cell and Gene Therapy Manufacturing Services Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Cell and Gene Therapy Manufacturing Services Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Cell and Gene Therapy Manufacturing Services Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Cell and Gene Therapy Manufacturing Services Sales Value, (2025-2030) & (US$ Million)
    Table 31. Thermo Fisher Scientific Basic Information List
    Table 32. Thermo Fisher Scientific Description and Business Overview
    Table 33. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of Thermo Fisher Scientific (2019-2024)
    Table 35. Thermo Fisher Scientific Recent Developments
    Table 36. Merck KGaA Basic Information List
    Table 37. Merck KGaA Description and Business Overview
    Table 38. Merck KGaA Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of Merck KGaA (2019-2024)
    Table 40. Merck KGaA Recent Developments
    Table 41. Charles River Laboratories Basic Information List
    Table 42. Charles River Laboratories Description and Business Overview
    Table 43. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of Charles River Laboratories (2019-2024)
    Table 45. Charles River Laboratories Recent Developments
    Table 46. Lonza Basic Information List
    Table 47. Lonza Description and Business Overview
    Table 48. Lonza Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of Lonza (2019-2024)
    Table 50. Lonza Recent Developments
    Table 51. Catalent Basic Information List
    Table 52. Catalent Description and Business Overview
    Table 53. Catalent Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of Catalent (2019-2024)
    Table 55. Catalent Recent Developments
    Table 56. WuXi AppTec Basic Information List
    Table 57. WuXi AppTec Description and Business Overview
    Table 58. WuXi AppTec Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of WuXi AppTec (2019-2024)
    Table 60. WuXi AppTec Recent Developments
    Table 61. Takara Bio Inc Basic Information List
    Table 62. Takara Bio Inc Description and Business Overview
    Table 63. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of Takara Bio Inc (2019-2024)
    Table 65. Takara Bio Inc Recent Developments
    Table 66. Nikon Corporation Basic Information List
    Table 67. Nikon Corporation Description and Business Overview
    Table 68. Nikon Corporation Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of Nikon Corporation (2019-2024)
    Table 70. Nikon Corporation Recent Developments
    Table 71. FUJIFILM Holdings Corporation Basic Information List
    Table 72. FUJIFILM Holdings Corporation Description and Business Overview
    Table 73. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of FUJIFILM Holdings Corporation (2019-2024)
    Table 75. FUJIFILM Holdings Corporation Recent Developments
    Table 76. F. Hoffmann-La Roche Basic Information List
    Table 77. F. Hoffmann-La Roche Description and Business Overview
    Table 78. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of F. Hoffmann-La Roche (2019-2024)
    Table 80. F. Hoffmann-La Roche Recent Developments
    Table 81. Oxford Biomedica Plc Basic Information List
    Table 82. Oxford Biomedica Plc Description and Business Overview
    Table 83. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of Oxford Biomedica Plc (2019-2024)
    Table 85. Oxford Biomedica Plc Recent Developments
    Table 86. Cell and Gene Therapy Catapult Basic Information List
    Table 87. Cell and Gene Therapy Catapult Description and Business Overview
    Table 88. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of Cell and Gene Therapy Catapult (2019-2024)
    Table 90. Cell and Gene Therapy Catapult Recent Developments
    Table 91. The Discovery Labs LLC Basic Information List
    Table 92. The Discovery Labs LLC Description and Business Overview
    Table 93. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of The Discovery Labs LLC (2019-2024)
    Table 95. The Discovery Labs LLC Recent Developments
    Table 96. RoslinCT Basic Information List
    Table 97. RoslinCT Description and Business Overview
    Table 98. RoslinCT Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of RoslinCT (2019-2024)
    Table 100. RoslinCT Recent Developments
    Table 101. JRS PHARMA Basic Information List
    Table 102. JRS PHARMA Description and Business Overview
    Table 103. JRS PHARMA Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of JRS PHARMA (2019-2024)
    Table 105. JRS PHARMA Recent Developments
    Table 106. FinVector Basic Information List
    Table 107. FinVector Description and Business Overview
    Table 108. FinVector Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of FinVector (2019-2024)
    Table 110. FinVector Recent Developments
    Table 111. ABL Basic Information List
    Table 112. ABL Description and Business Overview
    Table 113. ABL Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of ABL (2019-2024)
    Table 115. ABL Recent Developments
    Table 116. Resilience Basic Information List
    Table 117. Resilience Description and Business Overview
    Table 118. Resilience Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of Resilience (2019-2024)
    Table 120. Resilience Recent Developments
    Table 121. BioCentriq Basic Information List
    Table 122. BioCentriq Description and Business Overview
    Table 123. BioCentriq Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of BioCentriq (2019-2024)
    Table 125. BioCentriq Recent Developments
    Table 126. Porton Biopharma Limited Basic Information List
    Table 127. Porton Biopharma Limited Description and Business Overview
    Table 128. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of Porton Biopharma Limited (2019-2024)
    Table 130. Porton Biopharma Limited Recent Developments
    Table 131. Andelyn Biosciences Basic Information List
    Table 132. Andelyn Biosciences Description and Business Overview
    Table 133. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 134. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of Andelyn Biosciences (2019-2024)
    Table 135. Andelyn Biosciences Recent Developments
    Table 136. Commercializing Living Therapies Basic Information List
    Table 137. Commercializing Living Therapies Description and Business Overview
    Table 138. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 139. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of Commercializing Living Therapies (2019-2024)
    Table 140. Commercializing Living Therapies Recent Developments
    Table 141. Vibalogics Basic Information List
    Table 142. Vibalogics Description and Business Overview
    Table 143. Vibalogics Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 144. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of Vibalogics (2019-2024)
    Table 145. Vibalogics Recent Developments
    Table 146. Anemocyte Srl Basic Information List
    Table 147. Anemocyte Srl Description and Business Overview
    Table 148. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 149. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of Anemocyte Srl (2019-2024)
    Table 150. Anemocyte Srl Recent Developments
    Table 151. ElevateBio Basic Information List
    Table 152. ElevateBio Description and Business Overview
    Table 153. ElevateBio Cell and Gene Therapy Manufacturing Services Products, Services and Solutions
    Table 154. Revenue (US$ Million) in Cell and Gene Therapy Manufacturing Services Business of ElevateBio (2019-2024)
    Table 155. ElevateBio Recent Developments
    Table 156. Key Raw Materials Lists
    Table 157. Raw Materials Key Suppliers Lists
    Table 158. Cell and Gene Therapy Manufacturing Services Downstream Customers
    Table 159. Cell and Gene Therapy Manufacturing Services Distributors List
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
    Table 163. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Cell and Gene Therapy Manufacturing Services Product Picture
    Figure 2. Global Cell and Gene Therapy Manufacturing Services Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Cell and Gene Therapy Manufacturing Services Sales Value (2019-2030) & (US$ Million)
    Figure 4. Cell and Gene Therapy Manufacturing Services Report Years Considered
    Figure 5. Global Cell and Gene Therapy Manufacturing Services Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cell and Gene Therapy Manufacturing Services Revenue in 2023
    Figure 7. Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Allogeneic Picture
    Figure 9. Autologous Picture
    Figure 10. Viral Vector Picture
    Figure 11. Global Cell and Gene Therapy Manufacturing Services Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Cell and Gene Therapy Manufacturing Services Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Oncology Diseases
    Figure 14. Product Picture of Cardiovascular Diseases
    Figure 15. Product Picture of Orthopedic Diseases
    Figure 16. Product Picture of Ophthalmology Diseases
    Figure 17. Product Picture of Infectious Diseases
    Figure 18. Product Picture of Others
    Figure 19. Global Cell and Gene Therapy Manufacturing Services Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Cell and Gene Therapy Manufacturing Services Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America Cell and Gene Therapy Manufacturing Services Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America Cell and Gene Therapy Manufacturing Services Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe Cell and Gene Therapy Manufacturing Services Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe Cell and Gene Therapy Manufacturing Services Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific Cell and Gene Therapy Manufacturing Services Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific Cell and Gene Therapy Manufacturing Services Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America Cell and Gene Therapy Manufacturing Services Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America Cell and Gene Therapy Manufacturing Services Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa Cell and Gene Therapy Manufacturing Services Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa Cell and Gene Therapy Manufacturing Services Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions Cell and Gene Therapy Manufacturing Services Sales Value (%), (2019-2030)
    Figure 32. United States Cell and Gene Therapy Manufacturing Services Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States Cell and Gene Therapy Manufacturing Services Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States Cell and Gene Therapy Manufacturing Services Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe Cell and Gene Therapy Manufacturing Services Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe Cell and Gene Therapy Manufacturing Services Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe Cell and Gene Therapy Manufacturing Services Sales Value by Application (%), 2023 VS 2030
    Figure 38. China Cell and Gene Therapy Manufacturing Services Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China Cell and Gene Therapy Manufacturing Services Sales Value by Type (%), 2023 VS 2030
    Figure 40. China Cell and Gene Therapy Manufacturing Services Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan Cell and Gene Therapy Manufacturing Services Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan Cell and Gene Therapy Manufacturing Services Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan Cell and Gene Therapy Manufacturing Services Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea Cell and Gene Therapy Manufacturing Services Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea Cell and Gene Therapy Manufacturing Services Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea Cell and Gene Therapy Manufacturing Services Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia Cell and Gene Therapy Manufacturing Services Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Cell and Gene Therapy Manufacturing Services Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia Cell and Gene Therapy Manufacturing Services Sales Value by Application (%), 2023 VS 2030
    Figure 50. India Cell and Gene Therapy Manufacturing Services Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India Cell and Gene Therapy Manufacturing Services Sales Value by Type (%), 2023 VS 2030
    Figure 52. India Cell and Gene Therapy Manufacturing Services Sales Value by Application (%), 2023 VS 2030
    Figure 53. Cell and Gene Therapy Manufacturing Services Industrial Chain
    Figure 54. Cell and Gene Therapy Manufacturing Services Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS